首页> 外文OA文献 >The European Medicines Agency Review of Pomalidomide in Combination With Low‐Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

【2h】

The European Medicines Agency Review of Pomalidomide in Combination With Low‐Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

机译：欧洲药物局审查氯马al族与低剂量地塞米松组合用于治疗成人多发性骨髓瘤患者：人类使用药品委员会科学评估摘要

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zahra Hanaizi; Beatriz Flores; Robert Hemmings; Jorge Camarero; Arantxa Sancho‐Lopez; Tomas Salmonson; Christian Gisselbrecht; Edward Laane; Francesco Pignatti;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use [J] . Hanaizi Zahra, Flores Beatriz, Hemmings Robert, The oncologist . 2015,第3期

机译：欧洲药品管理局对帕马利度胺与小剂量地塞米松联用治疗成年多发性骨髓瘤患者的审查：人类用药品委员会的科学评估摘要
2. The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use [J] . Zahra Hanaizi, Beatriz Flores, Robert Hemmings, The oncologist . 2015,第3期

机译：欧洲药品管理局对帕马利度胺与小剂量地塞米松联合治疗成人多发性骨髓瘤的回顾：人类用药品委员会的科学评估摘要
3. The European Medicines Agency review of ofatumumab (Arzerra(R)) for the treatment of chronic lymphocytic leukemia in patients refractory to fludarabine and alemtuzumab: summary of the scientific assessment of the European medicines agency committee for medicinal products for human use. [J] . Gravanis I, Ersboll J, Skovlund E, The oncologist . 2010,第12期

机译：欧洲药物管理局对ofatumumab（Arzerra（R））在氟达拉滨和阿仑单抗难以治疗的患者中治疗慢性淋巴细胞性白血病的评论：欧洲药物管理局人类使用药品的委员会的科学评估摘要。
4. The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use [O] . Zahra Hanaizi, Beatriz Flores, Robert Hemmings, 2015

机译：欧洲药品管理局对帕马利度胺与小剂量地塞米松联合治疗成人多发性骨髓瘤的评价：人类用药品委员会的科学评估摘要
5. The European Medicines Agency Review of Ofatumumab (Arzerra®) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of the Scientific Assessment of the European Medicines Agency Committee for Medicinal Products for Human Use [O] . Gravanis, Iordanis, Ersbøll, Jens, Skovlund, Eva, 2010

机译：欧洲药物管理局对Ofatumumab（Arzerra®）的氟达拉滨和Alemtuzumab难治性患者治疗慢性淋巴细胞性白血病的评论：欧洲药物管理局人类使用药品的委员会的科学评估摘要

The European Medicines Agency Review of Pomalidomide in Combination With Low‐Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

著录项

引文网络

相似文献

相关主题

期刊订阅